Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects

Area of Science:

• Hematologic Malignancies
• Cancer Biology
• Stem Cell Research

Background:

• Mesenchymal stem cells (MSCs) support tumor growth and immune evasion in hematologic malignancies.
• Previously, supporting cells in multiple myeloma were considered healthy.
• Emerging evidence shows defects in MSCs from multiple myeloma patients (MM-MSCs) compared to healthy donors (ND-MSCs).

Purpose of the Study:

• To clarify confusions regarding the origin, identification, and characterization of MM-MSCs.
• To review the downstream effects and feedback circuits of MM-MSCs in cancer progression.
• To highlight the potential of MM-MSC distinctions as therapeutic targets.

Main Methods:

• Review of existing scientific literature on MM-MSCs and ND-MSCs.
• Analysis of gene and protein expression differences.
• Examination of the impact of myeloma cells on MSC function.

Main Results:

• MM-MSCs exhibit significant defects compared to ND-MSCs, including altered gene and protein expression.
• These abnormalities can develop rapidly upon co-culture with myeloma cells and persist long-term.
• MM-MSC dysfunction contributes to multiple myeloma progression.

Conclusions:

• Defects in MM-MSCs play a crucial role in supporting multiple myeloma progression.
• Understanding MM-MSC abnormalities provides novel therapeutic avenues.
• Further genetic analysis and improved disease models are needed to fully elucidate MSC-myeloma interactions.